Advertisement

International Journal of Hematology

, Volume 75, Issue 1, pp 78–84 | Cite as

Detection of Epstein-Barr Virus and Human T-Cell Lymphotropic Virus Type 1 in Malignant Nodal Lymphoma, Studied in Okinawa, a Subtropical Area in Japan

  • Jun-ichi Miyagi
  • Takayoshi Toda
  • Hiroshi Uezato
  • Kouichi Ohshima
  • Tsuyoshi Miyakuni
  • Nobuyuki Takasu
  • Masato Masuda
Case Report

Abstract

Formalin-fixed paraffin-embedded lymph node samples were collected from 100 cases of malignant nodal lymphoma documented in Okinawa in the period from 1973 through 1998. According to the new World Health Organization classification, 12 cases were Hodgkin’s lymphoma (HL). Eighty-eight cases of non-Hodgkin’s lymphoma (NHL) included 54 cases of T-cell type and 34 cases of B-cell type. Using polymerase chain reaction (PCR), Epstein-Barr virus (EBV) was detected in 11 cases (91.7%) of HL and in 57 cases (64.8%) of NHL, and human T-cell lymphotropic virus type 1 (HTLV-1) was detected in 23 cases (26.1%) of NHL. Clonal integration of HTLV-1 was detected in 10 (43.5%) of 23 HTLV-1 PCR-positive cases by the inverse PCR technique. The EBV-infected cells were detected by EBER-1 in situ hybridization in 11 (91.7%) of 12 HL cases and in 64 (72.7%) of 88 NHL cases. Irrespective of phenotype and tissue type of the malignant lymphoma, the rate of EBV-positive infection in Okinawa was higher than that in any other districts reported in Japan. This characteristic high rate of EBV-positive infection in Okinawa can be ascribed to various factors, such as racial and geographical differences.

Key words

EBV HTLV-1 Malignant lymphoma Subtropical area Okinawa 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hauzen HZ, Schulte-Holthausen H, Klein G, et al. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx.Nature. 1970;228:1056–1058.CrossRefGoogle Scholar
  2. 2.
    Weiss LM, Movahed LA, Warnke RA, Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin’s disease.N Engl J Med. 1989;320:502–506.CrossRefPubMedGoogle Scholar
  3. 3.
    MacMahon EM, Glass JD, Hayward SD, et al. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma.Lancet. 1991;338:969–973.CrossRefPubMedGoogle Scholar
  4. 4.
    Sasajima Y, Yamabe H, Kobashi Y, Hirai K, Mori S. High expression of the Epstein-Barr virus latent protein EB nuclear antigen-2 on pyothorax-associated lymphomas.Am J Pathol. 1993;143:1280–1285.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Harabuchi Y, Yamanaka N, Kataura A, et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma.Lancet. 1990;335:128–130.CrossRefPubMedGoogle Scholar
  6. 6.
    Niedobitek G, Herbst H, Young LS, et al. Epstein-Barr virus and carcinomas expression of the viral genome in an undifferentiated gastric carcinoma.Diagn Mol Pathol. 1992;1:103–108.CrossRefPubMedGoogle Scholar
  7. 7.
    Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lym- phoma.Proc Natl Acad Sci U S A. 1980;77:7415–7419.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Hinuma Y, Nagata K, Hanaoka M, et al. Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera.Proc Natl Acad Sci U S A. 1981;78:6476–6480.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    The T- and B-Cell Malignancy Study Group. Statistical analysis of clinico-pathological, virological and epidemiological data on lymphoid malignancies with special reference to adult T-cell leukemia/lymphoma: a report of the second nationwide study of Japan.Jpn J Clin Oncol. 1985;15:517–535.CrossRefGoogle Scholar
  10. 10.
    Tokunaga M, Imai S, Uemura Y, Tokudome T, Osato T, Sato E. Epstein-Barr virus in adult T-cell leukemia/lymphoma.Am J Pathol. 1993;143:1263–1269.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Ohshima K, Suzumiya J, Tasiro K, et al. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non- Hodgkin’s lymphoma of human immunodeficiency virus-negative Japanese.Am J Hematol. 1996;52:21–28.CrossRefPubMedGoogle Scholar
  12. 12.
    Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of hematological malignancies report of the clinical advisory committee meeting, Airlie House, Virginia, November 1997.Mod Pathol. 2000;13:193–207.CrossRefPubMedGoogle Scholar
  13. 13.
    Uezato H, Hagiwara K, Hosokawa A, et al. Comparative studies of the detection rates of Leishmania parasites from formalin, ethanol- fixed, frozen human skin specimens by polymerase chain reaction and Southern blotting.J Dermatol. 1998;25:623–631.CrossRefPubMedGoogle Scholar
  14. 14.
    Imai S, Usui N, Sugiura M, et al. Epstein-Barr virus genomic sequences and specific antibodies in cerebrospinal fluid in children with neurologic complications of acute and reactivated EBV infections.J Med Virol. 1993;40:278–284.CrossRefPubMedGoogle Scholar
  15. 15.
    Takemoto S, Matsuoka M, Yamaguchi K, Takatsuki K. A novel diagnostic method of Adult T-cell leukemia: monoclonal integration of Human T-cell lymphotropic virus type I provirus DNA detected by Inverse polymerase chain reaction.Blood. 1994;84:3080–3085.PubMedGoogle Scholar
  16. 16.
    Lymphoma study group of Japanese pathologists. The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities.Pathol Int. 2000;50:696–702.CrossRefGoogle Scholar
  17. 17.
    Chang KL, Chen Y-Y, Shibata D, Weiss LM. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues.Diagn Mol Pathol. 1992;1:246–255.CrossRefPubMedGoogle Scholar
  18. 18.
    Li D, Oda K, Mikata A, Yumoto N. Epstein-Barr virus genomes in Hodgkin’s disease and non-Hodgkin’s lymphomas.Pathol Int. 1995;45:735–741.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Zhou XG, Hamilton-Dutoit SJ, Yan QH, Pallesen G. The association between Epstein-Barr virus and Chinese Hodgkin’s disease.Int J Cancer. 1993;55:359–363.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Chan JKC, Yip TTC, Tsang WYW, Lau W, Wong CSC, Ma VWS. Detection of Epstein-Barr virus in Hodgkin’s disease occurring in an oriental population.Hum Pathol. 1995;26:314–318.CrossRefPubMedGoogle Scholar
  21. 21.
    Tomita Y, Ohsawa M, Kanno H, et al. Epstein-Barr virus in Hodgkin’s disease patients in Japan.Cancer. 1996;77:186–192.CrossRefPubMedGoogle Scholar
  22. 22.
    Kusuda M, Toriyama K, Kamidigo NO, Itakura H. A comparison of epidemiologic, histologic, and virologic studies on Hodgkin’s disease in western Kenya and Nagasaki, Japan.Am J Trop Med Hyg. 1998;59:801–807.CrossRefPubMedGoogle Scholar
  23. 23.
    Ambinder RF, Browning PJ, Lorenzana I, et al. Epstein-Barr virus and childhood Hodgkin’s disease in Honduras and the United States.Blood. 1993;81:462–467.PubMedGoogle Scholar
  24. 24.
    Leoncini L, Spina D, Nyong’o A, et al. Neoplastic cells of Hodg- kin’s disease show differences in EBV expression between Kenya and Italy.Int J Cancer. 1996;65:781–784.CrossRefPubMedGoogle Scholar
  25. 25.
    Chang KL, Albujar PF, Chen Y-Y, Johnson RM, Weiss LM. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin’s disease occurring in Peru.Blood. 1993;81:496–501.PubMedGoogle Scholar
  26. 26.
    Korbjuhn P, Anagnostopoulos I, Hummel M, et al. Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in human immunodeficiency virus-negative European peripheral pleomorphic T-cell lymphomas.Blood. 1993;82:217–223.PubMedGoogle Scholar
  27. 27.
    Hirose Y, Masaki Y, Shimizu S, et al. Association of Epstein-Barr virus with human immunodeficiency virus-negative T-cell lym- phomas in Japan, in situ hybridization, polymerase chain reaction and immunohistochemical studies.Leukemia. 1996;10:1673–1675.PubMedGoogle Scholar
  28. 28.
    Hummel M, Anagnostopoulos I, Korbjuhn P, Stein H. Epstein-Barr virus in B-cell non-Hodgkin’s lymphomas: unexpected infection patterns and different infection incidence in low-and high-grade types.J Pathol. 1995;175:263–271.CrossRefPubMedGoogle Scholar
  29. 29.
    Herbst H, Dallenbach F, Hummel M, et al. Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphomas.Blood. 1991;78:2666–2673.PubMedGoogle Scholar
  30. 30.
    Hirose Y, Masaki Y, Sasaki K, et al. Determination of Epstein-Barr virus association with B-cell lymphomas in Japan: study of 72 cases-in situ hybridization, polymerase chain reaction, immuno-histochemical studies.Int J Hematol. 1998;67:165–174.CrossRefPubMedGoogle Scholar
  31. 31.
    Mishima K, Horiuchi K, Kojya S, Takahashi H, Ohsawa M, Aozasa K. Epstein-Barr virus in patients with polymorphic reticulosis (lethal midline granuloma) from China and Japan.Cancer. 1994;73:3041–3046.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2002

Authors and Affiliations

  • Jun-ichi Miyagi
    • 1
  • Takayoshi Toda
    • 2
  • Hiroshi Uezato
    • 3
  • Kouichi Ohshima
    • 4
  • Tsuyoshi Miyakuni
    • 5
  • Nobuyuki Takasu
    • 1
  • Masato Masuda
    • 1
  1. 1.Second Department of Internal Medicine, Faculty of MedicineUniversity of the RyukyusOkinawaJapan
  2. 2.Department of Clinical Laboratory Medicine, Faculty of MedicineUniversity of the RyukyusOkinawaJapan
  3. 3.Department of Dermatology, Faculty of MedicineUniversity of the RyukyusOkinawaJapan
  4. 4.Department of Pathology, School of MedicineFukuoka UniversityFukuokaJapan
  5. 5.Japanese Red Cross Okinawa Blood CenterOkinawaJapan

Personalised recommendations